Search research articles
Contact Us
Filters
Showing results (881-890 of 1,266) with videos related to
Page
of 127
Sort By:
Behavioural and Cognitive Psychotherapy
|
April 26, 2018
The Role of Self-Esteem in Depression: A Longitudinal Study
Sven Hilbert, Stephan Goerigk, Frank Padberg, et al.
Oxidative Medicine and Cellular Longevity
|
August 25, 2020
DHA Supplementation Attenuates MI-Induced LV Matrix Remodeling and Dysfunction in Mice
I Habicht, G Mohsen, L Eichhorn, et al.
American Heart Journal
|
March 31, 2015
Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients
Bradi B Granger, Inger Ekman, Adrian F Hernandez, et al.
International Journal of Spine Surgery
|
July 24, 2020
High-Grade Spondylolisthesis in Adults: Current Concepts in Evaluation and Management
Kyle N Kunze, Daniel T Lilly, Jannat M Khan, et al.
Blood
|
April 30, 2005
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes
David P Steensma, Gordon W Dewald, Terra L Lasho, et al.
Clinical & Experimental Metastasis
|
November 23, 2022
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Cornelia L A Dewald, Lena S Becker, Timo C Meine, et al.
Respiratory Physiology & Neurobiology
|
May 20, 2024
Persistent glossopharyngeal nerve respiratory discharge patterns after ponto-medullary transection
Gijnovefa Kola, Eriko Hamada, Rishi R Dhingra, et al.
Journal of Medicinal Chemistry
|
September 1, 1986
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents
L D Wise, D E Butler, H A DeWald, et al.
Leukemia
|
April 7, 2006
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained
D P Steensma, R F McClure, J E Karp, et al.
Leukemia
|
July 30, 2003
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
E Paietta, D Neuberg, J M Bennett, et al.
Page
of 127
Search research articles
Search
Showing results (881-890 of 1,266) with videos related to
Sort By:
Page
of 127
Behavioural and Cognitive Psychotherapy
|
April 26, 2018
The Role of Self-Esteem in Depression: A Longitudinal Study
Sven Hilbert, Stephan Goerigk, Frank Padberg, et al.
Oxidative Medicine and Cellular Longevity
|
August 25, 2020
DHA Supplementation Attenuates MI-Induced LV Matrix Remodeling and Dysfunction in Mice
I Habicht, G Mohsen, L Eichhorn, et al.
American Heart Journal
|
March 31, 2015
Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients
Bradi B Granger, Inger Ekman, Adrian F Hernandez, et al.
International Journal of Spine Surgery
|
July 24, 2020
High-Grade Spondylolisthesis in Adults: Current Concepts in Evaluation and Management
Kyle N Kunze, Daniel T Lilly, Jannat M Khan, et al.
Blood
|
April 30, 2005
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes
David P Steensma, Gordon W Dewald, Terra L Lasho, et al.
Clinical & Experimental Metastasis
|
November 23, 2022
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Cornelia L A Dewald, Lena S Becker, Timo C Meine, et al.
Respiratory Physiology & Neurobiology
|
May 20, 2024
Persistent glossopharyngeal nerve respiratory discharge patterns after ponto-medullary transection
Gijnovefa Kola, Eriko Hamada, Rishi R Dhingra, et al.
Journal of Medicinal Chemistry
|
September 1, 1986
(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents
L D Wise, D E Butler, H A DeWald, et al.
Leukemia
|
April 7, 2006
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained
D P Steensma, R F McClure, J E Karp, et al.
Leukemia
|
July 30, 2003
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
E Paietta, D Neuberg, J M Bennett, et al.
Page
of 127